InsidersTradesSigma
Follow the 오리엔트바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has logged 8 public disclosures. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: 오리엔트. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations
Orient Bio is a company specializing in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development and distribution of biopharmaceutical products.